abstract |
This invention is directed to the crystalline potassium salt of a lipoxin A 4 analog of Formula (I): n nprocesses for preparing the crystalline potassium salts, methods for using them to treat disease-states characterized by inflammation, and pharmaceutical compositions comprising such crystalline potassium salts. |